Pfizer Inc (PFE)

45.68
+1.72(+3.91%)
After Hours
45.99
+0.31(+0.68%)
- Real-time Data
  • Volume:
    45,643,262
  • Bid/Ask:
    45.93/45.99
  • Day's Range:
    44.07 - 45.86

PFE Overview

Prev. Close
43.96
Day's Range
44.07-45.86
Revenue
55.52B
Open
44.17
52 wk Range
32.8-45.81
EPS
2.19
Volume
45,643,262
Market Cap
255.7B
Dividend (Yield)
1.56
(3.55%)
Average Vol. (3m)
26,017,403
P/E Ratio
20.08
Beta
0.72
1-Year Change
25.67%
Shares Outstanding
5,597,693,867
Next Earnings Date
Nov 02, 2021
What is your sentiment on Pfizer Inc?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc News

Pfizer Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyBuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
78500

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More
  • did our buddy Ray Ford buy into this stock? I have been out for a while.
    0
    • already two years destroying lives of families
      3
      • 50 tomorrow
        1
        • the dividend will be 6000 dollars or 0
          3
          • it does not pay even fee from brokers
            2
            • after 2year invest, it is for bullet
              2
              • to 50 is for paper clean your back part
                2
                • you win this price
                  2
                  • best liers of the year
                    2
                    • no one trust
                      2
                      • invest again to this MF
                        2
                        • it is for the laughter they had 200% income
                          3
                          • They laughed at me when I spoke of the $ 50, hahaha who laughs last laughs best! to The Moon 🚀🚀🚀
                            0
                            • So many big funds short this counter. Any reason why? Is it overvalued?
                              1
                              • It is UNDERvalued, not overvalued
                                0
                              • SuluchyOrgy bb then why the big funds short sell the stocks? Jst want to understand their intention
                                0
                            • It must be price min like amazon with all money
                              4
                              • you know money go somewhere else no to the stocks Macron and others have gold beds
                                4
                                • when BNTX hits $400 next week, all the Pfizer buyers will cry mama.
                                  6
                                  • Why the rise speed of BNTX's stock price is mush faster than that of Pfizer?
                                    2
                                  • because BNTX is a relatively new company
                                    0
                                • They claimed 100% efficiency people are not stupid
                                  3
                                  • Data from Izrael vaccine has max 39% efficiency where is the mistake?
                                    2
                                    • Data from Izrael vaccine has max 39% efficiency where is the mistake?
                                      1
                                      • Don't be so happy until Bourla steps down.
                                        4
                                        • More than 70 during month
                                          2
                                          • BNTX is going to hit $400 next week.... 🚀🚀🚀🚀
                                            6
                                            • welcome scientistic data
                                              2
                                              • the best vaccine with 39% efficiency Ivermectin 75%
                                                3
                                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.